Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activityarticle Published on 2023-05-312024-09-02 Journal: BMC Health Services Research [Category] 대상포진, [키워드] biologic DMARDs Biosimilar DMARDs Cost-utility analysis disease-modifying antirheumatic drugs Economic evaluation rheumatoid arthritis targeted synthetic DMARDs [DOI] 10.1186/s12913-023-09595-1 PMC 바로가기 [Article Type] article
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemicObservational Study Published on 2021-08-302022-10-04 Journal: Turkish Journal of Medical Sciences [Category] MERS, SARS, 임상, [키워드] biologic DMARDs Clinical characteristics COVID-19 COVID-19 pandemic diagnosis of COVID-19 disease Disease activity drug drug discontinuation Effect evaluate evaluated Inflammatory arthritis material no difference pandemic Patient patients PCR-confirmed COVID-19 predictor preference receiving recorded Result rheumatoid arthritis spondyloarthritis Symptom the patient therapy Treatment were recorded [DOI] 10.3906/sag-2012-5 PMC 바로가기 [Article Type] Observational Study
COVID-19 Among Patients With Inflammatory Rheumatic DiseasesImmunology Published on 2021-04-162022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, [키워드] 95%CI Admission Affect Analysis association biologic biologic DMARDs Characteristics Chronic kidney disease cohort study Comorbidity conducted Course COVID-19 death determine diagnose died disease DMARDs drug estimate female glucocorticoid Hospitalization Hospitalized ICU immune dysregulation Inconclusive Inflammatory innate immune responses intensive care invasive management medication novel coronavirus disease obesity objective ordinal logistic regression outcome Oxygen requirement oxygen support Patient patients with COVID-19 protective effect pulmonary disease Registered required Result rheumathoid diseases rheumatic disease SARS CoV-2 the disease treated Turkey variable Ventilation with COVID-19 [DOI] 10.3389/fimmu.2021.651715 PMC 바로가기 [Article Type] Immunology
Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept피하 아바타셉트를 투여받은 2~5세 다관절형 소아 특발성 관절염 환자의 디프테리아/파상풍 백신에 대한 항체 반응 유지Short Report Published on 2020-02-222024-07-28 Journal: Pediatric Rheumatology Online Journal [Category] 파상풍, [키워드] abatacept biologic DMARDs juvenile idiopathic arthritis vaccination [DOI] 10.1186/s12969-020-0410-x PMC 바로가기 [Article Type] Short Report
Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patientsArticle Published on 2018-11-012023-06-18 Journal: Clinical Rheumatology [Category] B형 간염, [키워드] antiviral therapy biologic DMARDs HBc-positive patients HBV reactivation HBV serology Immunosuppression Rheumatic diseases [DOI] 10.1007/s10067-018-4295-8
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritisReview Published on 2017-10-012023-06-15 Journal: Joint bone spine [Category] B형 간염, [키워드] biologic DMARDs hepatitis B rheumatoid arthritis [DOI] 10.1016/j.jbspin.2017.05.013 [Article Type] Review
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritisReview Published on 2017-10-012023-06-15 Journal: Joint bone spine [Category] B형 간염, [키워드] biologic DMARDs hepatitis B rheumatoid arthritis [DOI] 10.1016/j.jbspin.2017.05.013 [Article Type] Review